RM du Bois
- The source and role of RANTES in interstitial lung diseaseBy M Petrek, P Pantelidis, AM Southcott, P Lympany, P Safranek, CM Black, V Kolek, E Weigl and RM du BoisM PetrekP PantelidisAM SouthcottP LympanyP SafranekCM BlackV KolekE Weigl
- Corticosteroids in sarcoidosis: friend or foe?By RM du Bois
- Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsiesBy S Majumdar, D Li, T Ansari, P Pantelidis, CM Black, M Gizycki, RM du Bois and PK JefferyS MajumdarD LiT AnsariP PantelidisCM BlackM GizyckiRM du Bois
- Randomized trial of inhaled fluticasone propionate in chronic stable pulmonary sarcoidosis: a pilot studyBy RM du Bois, PM Greenhalgh, AM Southcott, NM Johnson and TA HarrisRM du BoisPM GreenhalghAM SouthcottNM Johnson
- The effect of lung biopsy on lung function in diffuse lung diseaseBy Z Daniil, FC Gilchrist, SJ Marciniak, P Pantelidis, P Goldstraw, U Pastorino and RM du BoisZ DaniilFC GilchristSJ MarciniakP PantelidisP GoldstrawU Pastorino
- Functional impairment in fibrosing alveolitis: relationship to reversible disease on thin section computed tomographyBy AU Wells, MB Rubens, RM du Bois and DM HansellAU WellsMB RubensRM du Bois
- Adhesion molecule expression in the lung: a comparison between normal and diffuse interstitial lung diseaseBy AM Southcott, I Hemingway, S Lorimer, K Sugars, PG Hellewell, CM Black, PK Jeffery, AJ Gearing, DO Haskard and RM du BoisAM SouthcottI HemingwayS LorimerK SugarsPG HellewellCM BlackPK JefferyAJ GearingDO Haskard
- Clearance of inhaled technetium-99m-DTPA as a clinical index of pulmonary vascular disease in systemic sclerosisBy OM Kon, Z Daniil, CM Black and RM du BoisOM KonZ DaniilCM Black
- Acute interstitial pneumoniaBy D Bouros, AC Nicholson, V Polychronopoulos and RM du BoisD BourosAC NicholsonV Polychronopoulos
- Clearance of inhaled 99mTc-DTPA predicts the clinical course of fibrosing alveolitisBy AU Wells, DM Hansell, NK Harrison, R Lawrence, CM Black and RM du BoisAU WellsDM HansellNK HarrisonR LawrenceCM Black
- Fibrosing alveolitis in systemic sclerosis: increase in memory T-cells in lung interstitiumBy AU Wells, S Lorimer, S Majumdar, NK Harrison, B Corrin, CM Black, PK Jeffery and RM du BoisAU WellsS LorimerS MajumdarNK HarrisonB CorrinCM BlackPK Jeffery
- Prediction of disease progression in idiopathic pulmonary fibrosisBy AU Wells and RM du Bois
- Diverse cellular TGF-beta 1 and TGF-beta 3 gene expression in normal human and murine lungBy RK Coker, GJ Laurent, S Shahzeidi, NA Hernandez-Rodriguez, P Pantelidis, RM du Bois, PK Jeffery and RJ McAnultyRK CokerGJ LaurentS ShahzeidiNA Hernandez-RodriguezP PantelidisRM du BoisPK Jeffery
- Neutrophil activation in fibrosing alveolitis: a comparison of lone cryptogenic fibrosing alveolitis and systemic sclerosisBy JB Cailes, C O'Connor, P Pantelidis, AM Southcott, MX Fitzgerald, CM Black and RM du BoisJB CailesC O'ConnorP PantelidisAM SouthcottMX FitzgeraldCM Black
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.